Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-13 Purchase | 2026-01-15 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,800 | $29.83 | $53,694 | 5,604,102 (Direct) | View |
| 2026-01-12 Purchase | 2026-01-14 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,900 | $27.54 | $79,866 | 5,602,302 (Direct) | View |
| 2025-12-31 Purchase | 2026-01-05 06:06 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 4,300 | $21.36 | $91,848 | 5,599,402 (Direct) | View |
| 2025-12-30 Purchase | 2026-01-02 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,900 | $21.73 | $63,017 | 5,595,102 (Direct) | View |
| 2025-12-18 Purchase | 2025-12-19 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 4,100 | $12.62 | $51,742 | 5,592,202 (Direct) | View |
| 2025-11-25 Purchase | 2025-11-28 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 4,600 | $8.37 | $38,502 | 5,588,102 (Direct) | View |
| 2025-11-07 Purchase | 2025-11-12 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 10,600 | $8.43 | $89,358 | 5,583,502 (Direct) | View |
| 2025-10-31 Purchase | 2025-11-04 06:16 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,300 | $9.26 | $21,298 | 5,572,902 (Direct) | View |
| 2025-04-25 Purchase | 2025-04-29 06:14 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 3,600 | $9.88 | $35,568 | 5,570,602 (Direct) | View |
| 2025-04-17 Purchase | 2025-04-22 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 5,400 | $8.98 | $48,492 | 5,567,002 (Direct) | View |
| 2025-04-07 Purchase | 2025-04-08 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 3,600 | $9.1 | $32,760 | 5,561,602 (Direct) | View |
| 2025-04-04 Purchase | 2025-04-07 07:50 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 5,500 | $8.73 | $48,015 | 5,558,002 (Direct) | View |
| 2025-01-10 Purchase | 2025-01-13 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,500 | $12.51 | $31,275 | 5,552,502 (Direct) | View |
| 2025-01-06 Purchase | 2025-01-08 06:10 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,900 | $13.58 | $39,391 | 5,550,002 (Direct) | View |
| 2025-01-03 Purchase | 2025-01-07 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 3,400 | $12.95 | $44,030 | 5,547,102 (Direct) | View |
| 2025-01-02 Purchase | 2025-01-06 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,000 | $11.97 | $23,940 | 5,543,702 (Direct) | View |
| 2024-12-31 Purchase | 2025-01-03 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,400 | $11.36 | $27,264 | 5,541,702 (Direct) | View |
| 2024-12-30 Purchase | 2025-01-02 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 3,200 | $11.12 | $35,584 | 5,539,302 (Direct) | View |
| 2024-11-21 Purchase | 2024-11-25 06:03 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 1,000 | $12.91 | $12,910 | 264,148 (Direct) | View |
| 2024-09-26 Purchase | 2024-09-30 06:04 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,500 | $14.63 | $21,945 | 5,536,102 (Direct) | View |
| 2024-08-12 Purchase | 2024-09-16 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 800 | $13.85 | $11,080 | 263,148 (Direct) | View |
| 2024-08-06 Purchase | 2024-08-08 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,000 | $13.81 | $27,620 | 5,534,602 (Direct) | View |
| 2024-08-05 Purchase | 2024-08-07 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 5,500 | $13.18 | $72,490 | 5,532,602 (Direct) | View |
| 2024-08-02 Purchase | 2024-08-05 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 1,000 | $15.15 | $15,150 | 262,348 (Direct) | View |
| 2024-07-23 Purchase | 2024-07-24 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,500 | $15.89 | $23,835 | 5,527,102 (Direct) | View |
| 2024-07-18 Purchase | 2024-07-22 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 1,000 | $16 | $16,000 | 261,348 (Direct) | View |
| 2024-06-13 Purchase | 2024-06-17 06:10 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 174,825 | $14.3 | $2,499,998 | 5,525,602 (Direct) | View |
| 2024-04-01 Purchase | 2024-04-03 06:10 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 3,000 | $19.08 | $57,240 | 5,350,777 (Direct) | View |
| 2024-03-22 Purchase | 2024-03-26 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,500 | $19.98 | $49,950 | 5,347,777 (Direct) | View |
| 2024-03-20 Purchase | 2024-03-22 06:02 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,500 | $17.68 | $26,520 | 5,345,277 (Direct) | View |
| 2024-03-05 Purchase(A) | 2024-03-07 09:41 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 3,500 | $12.49 | $43,715 | 5,343,777 (Direct) | View |
| 2024-03-05 Purchase | 2024-03-07 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 30,500 | $12.49 | $380,945 | 5,343,777 (Direct) | View |
| 2024-03-04 Purchase | 2024-03-06 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 4,100 | $13.03 | $53,423 | 5,340,277 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-11-13 Option Award | 2025-11-17 06:05 am | 2025-11-13 2035-11-13 | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 100,000 | $0 | 2,347,462 (Direct) | View |
| 2024-12-24 Option Award | 2024-12-27 4:19 pm | N/A 2034-12-24 | Greenwich LifeSciences Inc. | GLSI | Hallock Kenneth Director | 41,349 | $0 | 82,698 (Direct) | View |
| 2024-12-24 Option Award | 2024-12-27 4:19 pm | N/A 2034-12-24 | Greenwich LifeSciences Inc. | GLSI | Daugherty Frank Joseph Chief Medical Officer | 104,890 | $0 | 209,780 (Direct) | View |
| 2024-12-24 Option Award | 2024-12-27 4:19 pm | N/A 2034-12-24 | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,173,731 | $0 | 4,469,916 (Direct) | View |
| 2024-12-24 Option Award | 2024-12-27 4:19 pm | N/A 2034-12-24 | Greenwich LifeSciences Inc. | GLSI | Rothe Eric Director | 41,349 | $0 | 82,698 (Direct) | View |
| 2024-12-24 Option Award | 2024-12-27 4:19 pm | N/A 2034-12-24 | Greenwich LifeSciences Inc. | GLSI | McWilliams David Director | 61,984 | $0 | 123,968 (Direct) | View |
| 2024-12-24 Option Award | 2024-12-27 4:19 pm | N/A 2034-12-24 | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 149,818 | $0 | 299,636 (Direct) | View |